A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 539 participants.
Also called NCT02698839
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 539 participants
- Registry
-
NCT02698839
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02698839. Randomized; single masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2018-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)
- Acronym
- RCT
- Condition
- Coronary Artery Disease
- Intervention (Device)
- BuMA Supreme
- Intervention (Device)
- BuMA™
- Lead sponsor
- Sino Medical Sciences Technology Inc.
Record details
- Record id
cardio:ct-nct02698839- Content hash
836d9b8e0eb021235d49e3a5cc6540bd2e5f126a4e0eb8b8e2f6d5222e278462